Abstract:Osteoclasts are multinucleated cells of hematopoietic origin which are critically involved in physiological and pathological bone resorption. They develop from myeloid progenitors through characteristic gene expression changes and intercellular fusion. This process is directed by M-CSF and RANKL which are also able to trigger osteoclast development from bone marrow cells in vitro . Osteoclasts are conventionally visualized by histochemical staining followed by manual counting, which hinders kinetic studies and automated quantification. Here we describe two fluorescence-based assays for the real-time analysis of myeloid cell to osteoclast development (FRAMCO) in primary mouse bone marrow cell cultures. Both assays rely on red-to-green fluorescence conversion of the membrane-targeted tdTomato/membrane-targeted eGFP (mTmG) transgene by Cre recombinase driven by the osteoclast-specific cathepsin K promoter (Ctsk-Cre). In the first assay (FRAMCO1.1), osteoclast-specific gene expression triggers red-to-green color conversion of cells carrying both the Ctsk-Cre and mTmG transgenes. In the second assay (FRAMCO1.2), red-to-green fluorescence conversion is triggered by fusion of neighboring co-cultured bone marrow cells separately carrying either the Ctsk-Cre or the mTmG transgenes. The two assays were tested using a high-content confocal fluorescence imaging system, followed by automated quantification. The FRAMCO1.1 assay showed robust red-to-green fluorescence conversion of more than 50% of the culture (including mononuclear cells) within 3 days under osteoclastogenic conditions. The FRAMCO1.2 assay showed a less robust but still readily measurable red-to-green color conversion in multinuclear cells within 5 days of differentiation. The assays required both the Ctsk-Cre and the mTmG transgenes and gave no signals in parallel macrophage cultures. The proper functioning of the two assays was also confirmed at the DNA, mRNA and bulk protein level. The assay systems were validated using lisophosphatidylcholine, a previously reported inhibitor of preosteoclast fusion. Taken together, our assays allow high-throughput automated real-time analysis of two critical aspects of osteoclast development, facilitating the screening for novel drug candidates for the pharmacological control of osteoclast-mediated bone resorption.

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of Mtorc1 in Osteoclast Formation.

PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells.

Inactivation of Regulatory-associated Protein of Mtor (raptor)/mammalian Target of Rapamycin Complex 1 (mtorc1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice.

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

Mtorc1 Inhibits NF-κB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, in Vitro and in Mice

The Development and Identification of Animal Osteoblasts from Bone Marrow Culture

Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG.

Evaluation of culture conditions for osteoclastogenesis in RAW264.7 cells

A sequential culture approach to study osteoclast differentiation from nonadherent porcine bone marrow cells

mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis

Bone Size and Quality Regulation: Concerted Actions of mTOR in Mesenchymal Stromal Cells and Osteoclasts

Inactivation of mTORC1 Signaling in Osterix-expressing Cells Impairs B-cell Differentiation.

[Differentiation and functional expression of highly purified osteoclast-like cells in vitro].

Proteomic Study of Different Culture Medium Serum Volume Fractions on RANKL-dependent RAW264.7 Cells Differentiating into Osteoclasts

Osteocyte-intrinsic mTORC1 signaling restrains trabecular bone accrual in mice.

Establishment and validation of an efficient method for the 3D culture of osteoclasts in vitro

The mTORC2 Component Rictor Is Required for Load-Induced Bone Formation in Late-Stage Skeletal Cells

Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption

In vitro induction and culture of osteoclasts with Ti-alloy particles

Rictor/mTORC2 Loss in Osteoblasts Impairs Bone Mass and Strength.

Fluorescence-Based Real-Time Analysis of Osteoclast Development